Clinical Trials Browser

Phase 4 × Lutetium × 90 days × Clear all

NCT05803941 2026-06-04

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Phase 4 Recruiting

Prostatic Neoplasms